BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
Authors
Keywords
-
Journal
HISTOPATHOLOGY
Volume 68, Issue 4, Pages 520-532
Publisher
Wiley
Online
2015-07-14
DOI
10.1111/his.12778
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
- (2015) Chien-Feng Li et al. Oncotarget
- Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance
- (2014) Ching-Yih Lin et al. TUMOR BIOLOGY
- ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance
- (2013) H.-Y. Huang et al. CLINICAL CANCER RESEARCH
- Genome Wide Proteomics of ERBB2 and EGFR and Other Oncogenic Pathways in Inflammatory Breast Cancer
- (2013) Emma Yue Zhang et al. JOURNAL OF PROTEOME RESEARCH
- Over-expression of BCAT1, a c-Myc target gene, induces cell proliferation, migration and invasion in nasopharyngeal carcinoma
- (2013) Wen Zhou et al. Molecular Cancer
- BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
- (2013) Martje Tönjes et al. NATURE MEDICINE
- Deficiency in expression and epigenetic DNA Methylation of ASS1 gene in nasopharyngeal carcinoma: negative prognostic impact and therapeutic relevance
- (2013) Jui Lan et al. TUMOR BIOLOGY
- A Contemporary Update on Pathology Standards for Bladder Cancer: Transurethral Resection and Radical Cystectomy Specimens
- (2012) Donna E. Hansel et al. EUROPEAN UROLOGY
- Alpha-methylacyl coenzyme A racemase overexpression in gallbladder carcinoma confers an independent prognostic indicator
- (2012) Li-Ching Wu et al. JOURNAL OF CLINICAL PATHOLOGY
- Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder
- (2011) Zhongfa Zhang et al. BMC Medical Genomics
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 Update
- (2011) Morgan Rouprêt et al. EUROPEAN UROLOGY
- Posttranslational Modification of 6-phosphofructo-1-kinase as an Important Feature of Cancer Metabolism
- (2011) Andreja Šmerc et al. PLoS One
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
- (2010) Jordi Barretina et al. NATURE GENETICS
- Identification of Genes With Differential Expression in Chemoresistant Epithelial Ovarian Cancer Using High-Density Oligonucleotide Microarrays
- (2009) Woong Ju et al. ONCOLOGY RESEARCH
- Primary urothelial carcinoma of the upper tract: Important clinicopathological factors predicting bladder recurrence after surgical resection
- (2009) Wen-Wei Huang et al. PATHOLOGY INTERNATIONAL
- The present and future burden of urinary bladder cancer in the world
- (2009) Martine Ploeg et al. WORLD JOURNAL OF UROLOGY
- Aristolochic acid nephropathy: A worldwide problem
- (2008) Frédéric D. Debelle et al. KIDNEY INTERNATIONAL
- Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis
- (2008) Judith M. de Bont et al. NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started